Skip to main content
Mary Horowitz, MD, Oncology, Milwaukee, WI, Froedtert and the Medical College of Wisconsin Froedtert Hospital

MaryMHorowitzMDMS

Oncology Milwaukee, WI

Hematologic Oncology

Chief, Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin; Chief Scientific Director, Center for International Blood and Marrow Transplant Research

Dr. Horowitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Horowitz's full profile

Already have an account?

  • Office

    9200 W Wisconsin Ave
    Division of Hematology and Oncology/CIBMTR
    Milwaukee, WI 53226
    Phone+1 414-805-0700
    Fax+1 414-805-0714
  • Is this information wrong?

Education & Training

  • Medical College of Wisconsin Affiliated Hospitals
    Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 1987 - 1989
  • Medical College of Wisconsin Affiliated Hospitals
    Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 1980 - 1984
  • Medical College of Wisconsin
    Medical College of WisconsinClass of 1980

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 1981 - 2025
  • American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated Donors  
    Parameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica

Abstracts/Posters

  • Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lympho...
    Mary M. Horowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World E...
    Mary M. Horowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • BMT CTN Protocol 1506: A Phase 3 Trial of Gilteritinib As Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with FLT3-ITD+ AML
    Mary M. Horowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Press Mentions

  • Results of Study on COVID-19 Vaccine Response in Hematopoietic Cell Transplant Patients Published in eClinicalMedicine
    Results of Study on COVID-19 Vaccine Response in Hematopoietic Cell Transplant Patients Published in eClinicalMedicineMay 24th, 2023
  • Astellas and BMT CTN Announce Topline Results from Phase 3 MORPHO Trial of Gilteritinib
    Astellas and BMT CTN Announce Topline Results from Phase 3 MORPHO Trial of GilteritinibMarch 9th, 2023
  • Center for International Blood & Marrow Transplant Research Celebrates 50 Years
    Center for International Blood & Marrow Transplant Research Celebrates 50 YearsApril 22nd, 2022
  • Join now to see all

Grant Support

  • A Data Resource For Analyzing Blood And Marrow TransplantsNational Cancer Institute2008–2012
  • Blood &Marrow Transplant Clinical Trials Network Data Coordinating CenterNational Heart, Lung, And Blood Institute2011
  • BMT Clinical Research Network Data Coordinating CenterNational Heart, Lung, And Blood Institute2001–2010
  • Data Resource For Analyzing Blood &Marrow TransplantsNational Cancer Institute2003–2007
  • AML T-Cell DepletionNational Heart, Lung, And Blood Institute2005
  • Acute GVHD TreatmentNational Heart, Lung, And Blood Institute2005
  • PB Vs. BMNational Heart, Lung, And Blood Institute2004–2005
  • Multiple MyelomaNational Heart, Lung, And Blood Institute2004–2005
  • Fungal ProphylasixNational Heart, Lung, And Blood Institute2004–2005
  • Folicular LymphomaNational Heart, Lung, And Blood Institute2004–2005
  • Data Resource For Analyzing Blood And Marrow TransplantsNational Cancer Institute1998–2002
  • Cancer Following Bone Marrow TransplantationDivision Of Cancer Epidemiology And Genetics1995–2000
  • Transplants In Other CancersNational Cancer Institute1995–1998
  • Transplants In LeukemiaNational Cancer Institute1995–1998
  • Transplant BiologyNational Cancer Institute1995–1998
  • Collaborative Bone Marrow Transplant ProgramNational Cancer Institute1994–1998
  • A Collaborative Bone Marrow Transplant ProgramNational Cancer Institute1992–1993

Hospital Affiliations